EW earnings: next report 2026-07-23, real EPS beat/miss history, analyst consensus Buy, P/E 44.64. Updated 2026-07-23.
Edwards Lifesciences (EW) Research Hub
Edwards Lifesciences (EW) trades on NYSE, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 84.37 USD (-2.10%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 44.64, market cap 48.56B. This hub links to the full technical, earnings and options research available for EW.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NYSE, US |
| Last close | 84.37 USD (-2.10%) |
| 52-week range | 82.53 USD – 96.29 USD |
| Trend regime | Range |
| 14-day RSI | 36.4 (Bearish) |
| Trailing P/E | 44.64 |
| Market cap | 48.56B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-23 |
Available research for EW
Covered Call on EW: how it works, illustrative setup around the real 84.37 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on EW: how it works, illustrative setup around the real 84.37 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on EW: how it works, illustrative setup around the real 84.37 USD price, max profit/loss, breakeven and when to use it. Educational.
EW technical analysis: range, last 84.37 USD, RSI 36.4, 52w range 82.53 USD–96.29 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is EW in?
Edwards Lifesciences (EW) is classified under Healthcare (Medical - Devices), listed on NYSE, US.
Is EW in an uptrend or downtrend?
As of 2026-09-11, EW is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is EW's trailing P/E ratio?
EW's trailing P/E is 44.64, with a market cap of 48.56B. See the earnings research page for full valuation detail.
When does EW next report earnings?
EW is next scheduled to report earnings on 2026-07-23, with a consensus EPS estimate of 0.743 USD.